-
公开(公告)号：US12136214B2
公开(公告)日：2024-11-05
申请号：US18415125
申请日：2024-01-17
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , David S. Paik
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US12131471B2
公开(公告)日：2024-10-29
申请号：US18504795
申请日：2023-11-08
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , David S. Paik
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US12125572B2
公开(公告)日：2024-10-22
申请号：US18232231
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US12106477B2
公开(公告)日：2024-10-01
申请号：US18545563
申请日：2023-12-19
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A Moulton , David S. Paik
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US12045983B2
公开(公告)日：2024-07-23
申请号：US18504802
申请日：2023-11-08
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , David S. Paik , Mark A. Buckler , Vladimir Valtchinov
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
Patent Agency Ranking
46.发明授权公开(公告)号：US12008751B2
公开(公告)日：2024-06-11
申请号：US17314766
申请日：2021-05-07
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Mark A. Buckler
CPC classification number: G06T7/0012 , G06T7/10 , G16H50/20 , G16H70/60 , G06T2207/10081 , G06T2207/10088 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/20084 , G06T2207/30096
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
47.发明公开公开(公告)号：US20240021306A1
公开(公告)日：2024-01-18
申请号：US18242413
申请日：2023-09-05
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US20230420131A1
公开(公告)日：2023-12-28
申请号：US18243143
申请日：2023-09-07
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
49.发明授权公开(公告)号：US11791027B2
公开(公告)日：2023-10-17
申请号：US17838146
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US20230290433A1
公开(公告)日：2023-09-14
申请号：US17693229
申请日：2022-03-11
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ljubica Matic , Ulf Hedin
IPC: G16B5/20
CPC classification number: G16B5/20
Abstract: Atherosclerotic plaque phenotyping by image data analysis, e.g., using conventional computed tomography angiography (CTA) or other imaging modalities can elucidate the molecular signature of atherosclerotic lesions on a per-patient basis.
-
-
-
-
-
-
-
-
-
Search Results
68
records
(took 0.024 seconds)
